Sitagliptin/simvastatin
(Redirected from Juvisync)
Sitagliptin/Simvastatin is a combination medication used in the treatment of Type 2 diabetes and hypercholesterolemia. It contains two active ingredients: Sitagliptin, a dipeptidyl peptidase-4 inhibitor, and Simvastatin, a statin. This combination is used when diet and exercise alone does not adequately control blood sugar and cholesterol levels.
Mechanism of Action[edit | edit source]
Sitagliptin works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4). This results in increased levels of incretin hormones, which help to regulate insulin levels after meals and decrease the amount of glucose produced by the liver.
Simvastatin, on the other hand, works by inhibiting the enzyme HMG-CoA reductase, which is involved in the production of cholesterol in the liver. This results in lower levels of low-density lipoprotein (LDL), or "bad" cholesterol, and increased levels of high-density lipoprotein (HDL), or "good" cholesterol.
Indications[edit | edit source]
Sitagliptin/Simvastatin is indicated for the treatment of adults with Type 2 diabetes who also have hypercholesterolemia or mixed dyslipidemia. It is used in conjunction with a diet and exercise program to improve glycemic control and lower cholesterol levels.
Side Effects[edit | edit source]
Common side effects of Sitagliptin/Simvastatin include upper respiratory tract infection, headache, and diarrhea. Serious side effects may include pancreatitis, severe joint pain, and a condition called rhabdomyolysis, which can lead to kidney failure.
Contraindications[edit | edit source]
Sitagliptin/Simvastatin is contraindicated in patients with known hypersensitivity to either sitagliptin or simvastatin, in patients with active liver disease, and in women who are pregnant or breastfeeding.
Drug Interactions[edit | edit source]
Sitagliptin/Simvastatin may interact with other medications, including other antidiabetic drugs, anticoagulants, and certain antibiotics and antifungals. It is important to inform your healthcare provider of all medications you are currently taking.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
